A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.
Clinical trial NCT06143371 · COMPLETED
Trial details
- NCT number
- NCT06143371
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-21
- Primary completion
- 2025-11-10
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.